Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Trans R Soc Trop Med Hyg ; 107(6): 377-83, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23604864

ABSTRACT

BACKGROUND: Plasmodium vivax is the most prevalent malaria species in Brazil. The parasite-host coevolutionary process can be viewed as an 'arms race', in which adaptive genetic changes in one are eventually matched by alterations in the other. METHODS: Following the candidate gene approach we analyzed the CD40, CD40L and BLYS genes that participate in B-cell co-stimulation, for associations with P. vivax malaria. The study sample included 97 patients and 103 controls. We extracted DNA using the extraction and purification commercial kit and identified the following SNPs: -1C > T in the CD40 gene, -726T > C in the CD40L gene and the -871C > T in the BLyS gene using PCR-RFLP. We analyzed the genotype and allele frequencies by direct counting. We also compared the observed with the expected genotype frequencies using the Hardy-Weinberg equilibrium. RESULTS: The allele and genotype frequencies for these SNPs did not differ statistically between patient and control groups. Gene-gene interactions were not observed between the CD40 and BLYS and between the CD40L and BLYS genes. Overall, the genes were in Hardy-Weinberg equilibrium. Significant differences were not observed among the frequencies of antibody responses against P. vivax sporozoite and erythrocytic antigens and the CD40 and BLYS genotypes. CONCLUSIONS: The results of this study show that, although the investigated CD40, CD40L and BLYS alleles differ functionally, this variation does not alter the functionality of the molecules in a way that would interfere in susceptibility to the disease. The variants of these genes may influence the clinical course rather than simply increase or decrease susceptibility.


Subject(s)
B-Cell Activating Factor/genetics , CD40 Antigens/genetics , CD40 Ligand/genetics , Malaria, Vivax/genetics , Plasmodium vivax/genetics , Polymorphism, Single Nucleotide , Adult , Alleles , Antigens, Protozoan/genetics , Brazil , DNA, Protozoan/analysis , Disease Progression , Female , Gene Frequency , Genetic Predisposition to Disease , Genotype , Humans , Logistic Models , Malaria, Vivax/immunology , Male , Young Adult
2.
J Infect Dev Ctries ; 7(3): 243-52, 2013 Mar 14.
Article in English | MEDLINE | ID: mdl-23493003

ABSTRACT

INTRODUCTION: In remote areas of the Amazon Region, diagnosis of malaria by microscopy is practically impossible. This study aimed to evaluate the performance of two rapid diagnostic tests (RDTs) targeting different malaria antigens stored at room temperature in the Brazilian Amazon Region. METHODOLOGY: Performance of the OptiMal Pf/Pan test and ICT-Now Pf/Pan test was analyzed retrospectively in 1,627 and 1,602 blood samples, respectively. Tests were performed over a 15-month period. Kits were stored at room temperature in five community health centres located in the Brazilian Amazon Region. RDT results were compared with thick blood smear (TBS) results to determine sensitivity, specificity, and accuracy of the RDT. RESULTS: The sensitivities of the OptiMal Pf/Pan test were 79.7% for Plasmodium falciparum malaria diagnosis and 85.7% for non-P. falciparum infections. The results showed a crude agreement of 88.5% for P. falciparum, and 88.3% for non-P. falciparum infections (Kappa index = 0.74 and 0.75, respectively). For the ICT-Now Pf/Pan test (CI 95%), the sensitivities were 87.9% for P. falciparum malaria diagnosis and 72.5% for non-P. falciparum infection. Crude agreement between the ICT-Now Pf/Pan test and TBS was 91.4% for P. falciparum and 79.7% for non-P. falciparum infection. The Kappa index was 0.81 and 0.59 for the final diagnosis of P. falciparum and non-P. falciparum, respectively. Higher levels of parasitaemia were associated with higher crude agreement between RDT and TBS. CONCLUSIONS: The sensitivities of RDTs stored at room temperature over a 15-month period and performed in field conditions were lower than those previously reported.


Subject(s)
Antigens, Protozoan/blood , Diagnostic Tests, Routine/methods , Malaria, Falciparum/diagnosis , Plasmodium falciparum/isolation & purification , Specimen Handling/methods , Adolescent , Adult , Aged , Brazil , Child , Child, Preschool , Female , Humans , Immunoassay/methods , Infant , Male , Middle Aged , Plasmodium falciparum/immunology , Sensitivity and Specificity , Temperature , Time Factors , Young Adult
3.
Malar J ; 9: 178, 2010 Jun 23.
Article in English | MEDLINE | ID: mdl-20573199

ABSTRACT

BACKGROUND: Plasmodium vivax circumsporozoite variants have been identified in several geographical areas. The real implication of the genetic variation in this region of the P. vivax genome has been questioned for a long time. Although previous studies have observed significant association between VK210 and the Duffy blood group, we present here that evidences of this variation are limited to the CSP central portion. METHODS: The phylogenetic analyses were accomplished starting from the amplification of conserved domains of 18 SSU RNAr and Cyt B. The antibodies responses against the CSP peptides, MSP-1, AMA-1 and DBP were detected by ELISA, in plasma samples of individuals infected with two P. vivax CS genotypes: VK210 and P. vivax-like. RESULTS: These analyses of the two markers demonstrate high similarity among the P. vivax CS genotypes and surprisingly showed diversity equal to zero between VK210 and P. vivax-like, positioning these CS genotypes in the same clade. A high frequency IgG antibody against the N- and C-terminal regions of the P. vivax CSP was found as compared to the immune response to the R- and V- repetitive regions (p = 0.0005, Fisher's Exact test). This difference was more pronounced when the P. vivax-like variant was present in the infection (p = 0.003, Fisher's Exact test). A high frequency of antibody response against MSP-1 and AMA-1 peptides was observed for all P. vivax CS genotypes in comparison to the same frequency for DBP. CONCLUSIONS: This results target that the differences among the P. vivax CS variants are restrict to the central repeated region of the protein, mostly nucleotide variation with important serological consequences.


Subject(s)
Genetic Variation , Merozoite Surface Protein 1/genetics , Plasmodium vivax/genetics , Antigens, Protozoan/genetics , Antigens, Protozoan/immunology , Cytochromes b/genetics , Genotype , Humans , Malaria, Vivax/parasitology , Membrane Proteins/genetics , Membrane Proteins/immunology , Merozoite Surface Protein 1/immunology , Molecular Sequence Data , Phylogeny , Plasmodium vivax/classification , Polymerase Chain Reaction , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Receptors, Cell Surface/genetics , Receptors, Cell Surface/immunology , Repetitive Sequences, Nucleic Acid , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...